Asia-Pacific Heart Valve Repair and Replacement Market, By Product (Surgical Heart Valves Replacement, Surgical Heart Valves Repair, TAVI / TAVR Valves, Grafts, Patches, Medication and Others), Procedure (Surgical Procedure and Non-Surgical Procedure), Indication (Valvular Stenosis, Valvular Insufficiency, Mitral Valve Prolapse and Others), End User (Hospital, Speciality Centers, Cardiac Catheterization Lab, Ambulatory Surgical Centers and Others), Distribution Channel (Direct Tender, Retail Sales and Others), Country (China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific) Industry Trends and Forecast to 2028.
Market Analysis and Insights: Asia-Pacific Heart Valve Repair and Replacement Market
Asia-Pacific heart valve repair and replacement market is expected to gain market growth in the forecast period of 2021 to 2028. Data Bridge Market Research analyses that the Asia-Pacific heart valve repair and replacement market is growing with a CAGR of 12.0% in the forecast period of 2021 to 2028 and is expected to reach USD 2,119.32 million by 2028. Rise in incidence of valvular heart defects and technological advancement is expected to drive the demand of the market in the forecast period.
Heart valves play a pivotal role in this one-way blood flow, inaugural and closing with each heartbeat. The pressure changes on either side of the valves cause them to open their flap-type “doors” (called cups or leaflets) at just the right time, then close compactly to avert a backflow of blood. Doctors treat valves with medicines if it is not severe else it is treated with surgeries to repair or replace the valve.
Valve repair can primarily be done on congenital valve defects and has a good success record with treating mitral valve defects whereas severe valve damage implies the valve must be replaced and most often entails the aortic or mitral valve. It is also helpful in treating any valve disease that is life-threatening. Some patients may need more than one valve repaired or can be replaced.
The rise in demand for heart valve repair and replacement surgery is because of growing incidences of chronic diseases, rising demand for minimally invasive surgeries and increasing number of heart valve repair and replacement procedures propelling the demand for the heart valve repair and replacement market in the forecast period. However, the high cost and shortage of skilled professionals may hamper the heart valve repair and replacement market growth in the forecast period.
The heart valve repair and replacement market report provides details of market share, new developments, and product pipeline analysis, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, product approvals, strategic decisions, product launches, geographic expansions, and technological innovations in the market. To understand the analysis and the market scenario contact us for an Analyst Brief, our team will help you create a revenue impact solution to achieve your desired goal.
Asia-Pacific Heart Valve Repair and Replacement Market Scope and Market Size
Asia-Pacific heart valve repair and replacement market is segmented on the basis of product, procedure, indication, end user and distribution channel. The growth among segments helps you analyse niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.
- On the basis of product, the heart valve repair and replacement market is segmented into surgical heart valves replacement, surgical heart valves repair, TAVI / TAVR valves, grafts, patches, medication and others. In 2021, surgical heart valves replacement is expected to dominate the market due to rise in lifestyle associated disorders such as cardiovascular diseases among Asian population.
- On the basis of procedure, the heart valve repair and replacement market is segmented into surgical procedure and non-surgical procedure. In 2021, surgical procedure segment is expected to dominate the heart valve repair and replacement market because of rising incidence of valvular heart defects.
- On the basis of indication, the heart valve repair and replacement market is segmented into valvular stenosis, valvular insufficiency, mitral valve prolapse and others. In 2021, valvular stenosis segment is expected to dominate the heart valve repair and replacement market because of increase in number of heart valve repair and replacement procedures.
- On the basis of end user, the heart valve repair and replacement market is segmented into hospital, speciality centers, cardiac catheterization lab, ambulatory surgical centers and others. In 2021, hospital segment is expected to dominate the heart valve repair and replacement market because of increasing pool of patients and rise in healthcare expenditure by hospital in medical devices.
- On the basis of distribution channel, the heart valve repair and replacement market is segmented into direct tender, retail sales and others. In 2021, direct tender segment is expected to dominate the heart valve repair and replacement market because of broad range of products availability.
Asia-Pacific Heart Valve Repair and Replacement Market Country Level Analysis
The heart valve repair and replacement market is analysed and market size information is provided by product type, application, technology, and end user.
The countries covered in the heart valve repair and replacement market report are China, Japan, India, South Korea, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines, Rest of Asia-Pacific.
Asia-Pacific heart valve repair and replacement market is expected to dominate the market due to increase in incidences of valvular heart diseases in the region. Japan is expected to dominate the Asia-Pacific heart valve repair and replacement market due to rise in disposable income and medical tourism in the country.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as new sales, replacement sales, country demographics, regulatory acts and import-export tariffs are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of Asia-Pacific brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of sales channels are considered while providing forecast analysis of the country data.
Increasing Partnership and Rising rates of obesity in the Asia-Pacific Heart Valve Repair and Replacement Market is Creating New Opportunities for Players in the Asia-Pacific Heart Valve Repair and Replacement Market
Asia-Pacific heart valve repair and replacement market also provides you with detailed market analysis for every country growth in particular industry with the heart valve repair and replacement market sales, impact of advancement in the Asia-Pacific heart valve repair and replacement market and changes in regulatory scenarios with their support for the heart valve repair and replacement market. The data is available for historic period 2010 to 2019.
Competitive Landscape and Heart Valve Repair and Replacement Market Share Analysis
Heart valve repair and replacement market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, production sites and facilities, company strengths and weaknesses, product launch, product trials pipelines, product approvals, patents, product width and breadth, application dominance, technology lifeline curve. The above data points provided are only related to the company’s focus related to heart valve repair and replacement market.
The major players covered in the report are CardiaMed, Edwards Lifesciences Corporation, Medtronic, Abbott, LivaNova PLC, Meril Life Sciences Pvt. Ltd., and BIOTRONIK SE & Co. KG among other players. DBMR analysts understand competitive strengths and provide competitive analysis for each competitor separately.
Many product launch and agreement are also initiated by the companies’ worldwide which are also accelerating the heart valve repair and replacement market.
For instance,
- In December 2020, Abbott launched a minimally-invasive heart valve repair device in India to treat mitral regurgitation. It will help restore the heart’s ability to pump oxygenated blood more efficiently and help improve the company’s revenue.
- In July 2020, LivaNova PLC announced its new product Perceval plus aortic heart valve in Europe. It will facilitate minimally invasive cardiac surgery and help the company to expand its business further.
Collaboration, joint ventures and other strategies by the market player is enhancing the company market in the Asia-Pacific heart valve repair and replacement market which also provides the benefit for organisation to improve their offering for heart valve repair and replacement market.
SKU-